Nonsurgical Options for the Treatment of Basal Cell Carcinoma

被引:25
作者
Paoli, John [1 ,2 ]
Gyllencreutz, Johan Dahlen [3 ]
Fougelberg, Julia [1 ,2 ]
Backman, Eva Johansson [1 ,2 ]
Modin, Maja [1 ,2 ]
Polesie, Sam [1 ,2 ]
Zaar, Oscar [1 ,2 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Dermatol & Venereol, Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Dermatol & Venereol, Reg Vastra Gotaland, Gothenburg, Sweden
[3] Skaraborg Hosp, Dept Dermatol & Venereol, Skovde, Sweden
来源
DERMATOLOGY PRACTICAL & CONCEPTUAL | 2019年 / 9卷 / 02期
关键词
basal cell carcinoma; destructive therapy; topical drugs; radiotherapy; hedgehog inhibitors; AMINOLEVULINATE PHOTODYNAMIC THERAPY; INGENOL MEBUTATE GEL; METHYL AMINOLEVULINATE; TOPICAL IMIQUIMOD; FOLLOW-UP; CURETTAGE-CRYOSURGERY; 5-AMINOLEVULINIC ACID; EUROPEAN GUIDELINES; SURGICAL EXCISION; HEDGEHOG PATHWAY;
D O I
10.5826/dpc.0902a01
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objectives: The aim of this review article is to summarize the effectiveness, potential adverse events, and indications of the main nonsurgical treatment alternatives for basal cell carcinoma. Methods: An extensive literature review was carried out. The most relevant articles were discussed and selected by the authors in order to provide a brief but evidence-based overview of the most common nonsurgical methods used for treating basal cell carcinoma. Results: Although surgery and Mohs micrographic surgery are often considered the optimal treatment options for basal cell carcinoma, these tumors can also be treated successfully with destructive techniques (eg, curettage alone, cryosurgery, or electrodesiccation), photodynamic therapy, topical drugs (eg, 5-fluorouracil, imiquimod, or ingenol mebutate), radiotherapy, or hedgehog pathway inhibitors. When choosing between these alternatives, physicians must take into consideration the tumor's size, location, and histopathological subtype. Special care should be taken when treating recurrent tumors. Furthermore, physician experience is of great importance when using destructive techniques. Finally, patient preference, potential adverse events, and cosmetic outcome should also be considered. Conclusions: Dermatologists and physicians treating basal cell carcinoma should have knowledge of and experience with the large arsenal of therapeutic alternatives available for the successful, safe, and individualized management of patients with basal cell carcinoma.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 74 条
  • [1] An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma
    Ally, Mina Sarah
    Aasi, Sumaira
    Wysong, Ashley
    Teng, Claudia
    Anderson, Eric
    Bailey-Healy, Irene
    Oro, Anthony
    Kim, Jinah
    Chang, Anne Lynn
    Tang, Jean Yuh
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (05) : 904 - U304
  • [2] Dermatoscopy of basal cell carcinoma: Morphologic variability of global and local features and accuracy of diagnosis
    Altamura, Davide
    Menzies, Scott W.
    Argenziano, Giuseppe
    Zalaudek, Iris
    Soyer, H. Peter
    Sera, Francesco
    Avramidis, Michelle
    DeAmbrosis, Kathryn
    Fargnoli, Maria Concetta
    Peris, Ketty
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (01) : 67 - 75
  • [3] Vascular structures in skin tumors - A dermoscopy study
    Argenziano, G
    Zalaudek, I
    Corona, R
    Sera, F
    Cicale, L
    Petrillo, G
    Ruocco, E
    Hofmann-Wellenhof, R
    Soyer, HP
    [J]. ARCHIVES OF DERMATOLOGY, 2004, 140 (12) : 1485 - 1489
  • [4] Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma
    Arits, A. H. M. M.
    Spoorenberg, E.
    Mosterd, K.
    Nelemans, P.
    Kelleners-Smeets, N. W. J.
    Essers, B. A. B.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : 1501 - 1507
  • [5] Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
    Arits, Aimee H. M. M.
    Mosterd, Klara
    Essers, Brigitte A. B.
    Spoorenberg, Eefje
    Sommer, Anja
    De Rooij, Michette J. M.
    van Pelt, Han P. A.
    Quaedvlieg, Patricia J. F.
    Krekels, Gertruud A. M.
    van Neer, Pierre A. F. A.
    Rijzewijk, Joris J.
    van Geest, Adrienne J.
    Steijlen, Peter M.
    Nelemans, Patty J.
    Kelleners-Smeets, Nicole W. J.
    [J]. LANCET ONCOLOGY, 2013, 14 (07) : 647 - 654
  • [6] Treatment of basal cell carcinoma with curettage alone
    Barlow, James O.
    Zalla, Mark J.
    Kyle, Amber
    DiCaudo, David J.
    Lim, Katherine K.
    Yiannias, James A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (06) : 1039 - 1045
  • [7] Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma:: a 5 year randomized trial
    Basset-Seguin, Nicole
    Ibbotson, Sally H.
    Emtestam, Lennart
    Tarstedt, Mikael
    Morton, Colin
    Maroti, Marianne
    Calzavara-Pinton, Piergiacomo
    Varma, Sandeep
    Roelandts, Rik
    Wolf, Peter
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2008, 18 (05) : 547 - 553
  • [8] Interventions for basal cell carcinoma of the skin: systematic review
    Bath-Hextall, F
    Bong, J
    Perkins, W
    Williams, H
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7468): : 705 - 708
  • [9] Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial
    Bath-Hextall, Fiona
    Ozolins, Mara
    Armstrong, Sarah J.
    Colver, Graham B.
    Perkins, William
    Miller, Paul S. J.
    Williams, Hywel C.
    [J]. LANCET ONCOLOGY, 2014, 15 (01) : 96 - 105
  • [10] A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma
    Berroeta, L.
    Clark, C.
    Dawe, R. S.
    Ibbotson, S. H.
    Fleming, C. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (02) : 401 - 403